The global market for implantable pacemakers is projected to see moderate, steady growth through 2023, resulting in a sum of more than $5.32 billion, according to a recent report.

MaxQ AI has announced that its AI-based intracranial hemorrhage (ICH) and stroke software will soon be integrated into Philips CT scanners.

A drop in income over six years was linked to a higher likelihood of CVD in a recent analysis of the ARIC study, suggesting financial stress might be a predictor of worse heart health in the U.S.

VIDA Diagnostics, a Coralville, Iowa-based medical imaging company, has announced a new distribution deal with TeraRecon.

Radiology is evolving, consolidating and all the while innovating in this time of transition from volume to value across U.S. healthcare. A compressed field reflects the shape of the changed—and still changing—marketplace.

NYC Health + Hospitals announced Wednesday, Oct. 9, it plans to invest nearly a quarter of $1 billion to upgrade its imaging capabilities, hoping to standardize care across the vast enterprise.

As more businesses begin to implement state-of-the-art technologies, one industry expert is predicting AI will boost the global economy by $14 trillion by the year 2035.

Imaging giant GE Healthcare announced this week that it’s teaming with biotech firm Theragnostics in a bid to improve prostate cancer treatment.